We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00562510
Recruitment Status : Terminated (recruitment lower than estimated)
First Posted : November 22, 2007
Last Update Posted : June 9, 2015
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Pedro Cahn, The Huesped Foundation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : December 2010
  Study Completion Date : December 2010